COM:ARCABIO
Oruka Therapeutics
- Stock
Last Close
2.50
30/08 20:00
Market Cap
49.90M
Beta: -
Volume Today
290.85K
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '13 | Dec '14 | Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
net income | -6.94M - | -9.69M 39.63% | -11.45M 18.12% | -16.44M 43.68% | -18.49M 12.44% | -7.93M 57.10% | -5.48M 30.90% | -9.74M 77.64% | -19.32M 98.42% | -9.93M 48.63% | -5.34M 46.21% | |
depreciation and amortization | 26K - | 12K 53.85% | 19K 58.33% | 320K 1,584.21% | 356K 11.25% | 22K 93.82% | 89K 304.55% | 93K 4.49% | 91K 2.15% | 114K 25.27% | 111K 2.63% | |
deferred income tax | -19K - | 17K 189.47% | -141K - | 872K 718.44% | -1.09M 225% | -908K - | ||||||
stock based compensation | 283K - | 647K 128.62% | 599K 7.42% | 576K 3.84% | 458K 20.49% | 273K 40.39% | 151K 44.69% | 43K 71.52% | 497K 1,055.81% | 556K 11.87% | 686K 23.38% | |
change in working capital | 1.34M - | -443K 133.01% | 104K 123.48% | 400K 284.62% | 85K 78.75% | -608K 815.29% | 441K 172.53% | 1.88M 325.62% | -28K 101.49% | -1.66M 5,832.14% | -472K 71.58% | |
accounts receivables | ||||||||||||
inventory | ||||||||||||
accounts payables | 532K - | 198K 62.78% | -431K 317.68% | 841K 295.13% | -583K 169.32% | -392K 32.76% | 188K 147.96% | 1.10M 485.64% | -411K 137.33% | -783K 90.51% | 28K 103.58% | |
other working capital | 810K - | -641K 179.14% | 535K 183.46% | -441K 182.43% | 668K 251.47% | -216K 132.34% | 253K 217.13% | 776K 206.72% | 383K 50.64% | -878K 329.24% | -500K 43.05% | |
other non cash items | 67K - | 189K 182.09% | 180K 4.76% | 102K 43.33% | 2K 98.04% | 141K 6,950% | -872K 718.44% | 1.09M 225% | 5K 99.54% | 908K 18,060% | ||
net cash provided by operating activities | -5.29M - | -9.41M 77.87% | -10.53M 11.99% | -14.99M 42.27% | -17.47M 16.58% | -8.24M 52.82% | -4.80M 41.76% | -7.72M 60.90% | -18.76M 142.87% | -10.91M 41.84% | -5.01M 54.05% | |
investments in property plant and equipment | -32K - | -19K 40.63% | -11K 42.11% | -12K 9.09% | -3K 75% | -4K 33.33% | -4K 0% | -19K 375% | -43K 126.32% | -2K 95.35% | ||
acquisitions net | ||||||||||||
purchases of investments | -20.50M - | -5.47M 73.32% | ||||||||||
sales maturities of investments | 4.10M - | 18.40M 348.56% | 3.05M 83.42% | |||||||||
other investing activites | ||||||||||||
net cash used for investing activites | -32K - | -19K 40.63% | -11K 42.11% | -16.41M 149,118.18% | 12.93M 178.75% | 3.05M 76.44% | -4K 100.13% | -19K 375% | -43K 126.32% | -2K 95.35% | ||
debt repayment | -349K - | -408K 16.91% | ||||||||||
common stock issued | 1.74M - | 9.04M 419.13% | 37M 309.38% | 6.55M - | 3.53M 46.08% | 7.28M 106.14% | 50.89M 599.00% | 24.07M 52.71% | ||||
common stock repurchased | ||||||||||||
dividends paid | ||||||||||||
other financing activites | 17.41M - | -1.01M 105.83% | -3.01M 196.26% | -704K - | -428K 39.20% | -372K 13.08% | -2.03M 446.77% | -977K 51.97% | ||||
net cash used provided by financing activities | 19.16M - | 8.02M 58.12% | 33.99M 323.69% | 5.85M - | 3.10M 46.91% | 6.56M 111.34% | 48.45M 638.60% | 23.09M 52.34% | ||||
effect of forex changes on cash | ||||||||||||
net change in cash | 13.84M - | -1.40M 110.13% | 23.45M 1,772.47% | -31.40M 233.92% | 1.30M 104.14% | -2.09M 260.95% | 1.75M 183.81% | 40.71M 2,219.54% | 4.29M 89.47% | -10.91M 354.52% | -5.01M 54.06% | |
cash at beginning of period | 2.92M - | 16.76M 473.84% | 15.35M 8.37% | 38.80M 152.72% | 7.40M 80.93% | 8.70M 17.58% | 6.61M 24.06% | 8.36M 26.56% | 49.07M 486.76% | 53.36M 8.74% | 42.45M 20.45% | |
cash at end of period | 16.76M - | 15.35M 8.37% | 38.80M 152.72% | 7.40M 80.93% | 8.70M 17.58% | 6.61M 24.06% | 8.36M 26.56% | 49.07M 486.76% | 53.36M 8.74% | 42.45M 20.45% | 37.43M 11.81% | |
operating cash flow | -5.29M - | -9.41M 77.87% | -10.53M 11.99% | -14.99M 42.27% | -17.47M 16.58% | -8.24M 52.82% | -4.80M 41.76% | -7.72M 60.90% | -18.76M 142.87% | -10.91M 41.84% | -5.01M 54.05% | |
capital expenditure | -32K - | -19K 40.63% | -11K 42.11% | -12K 9.09% | -3K 75% | -4K 33.33% | -4K 0% | -19K 375% | -43K 126.32% | -2K 95.35% | ||
free cash flow | -5.32M - | -9.43M 77.16% | -10.54M 11.88% | -15.00M 42.24% | -17.48M 16.51% | -8.25M 52.80% | -4.80M 41.74% | -7.74M 61.17% | -18.80M 142.83% | -10.91M 41.96% | -5.01M 54.06% |
All numbers in USD (except ratios and percentages)